• We are available for your help 24/7
  • Email: info@isindexing.com, submission@isindexing.com

Paper Details

Insights into Binding of Potential Antitumor Quinoxaline Analogues against Cyclin Dependent Kinase 2 Using Docking Studies

Arun Kumar V.A., Keshav Mohan

Journal Title:Journal of Chemical, Biological and physical sciences

Cyclin-dependent kinases (CDKs) belongs to a family of protein kinases and CDK2 consideredas potential anti-cancer target among CDKs. A CDK2 inhibitor is a chemical that inhibits the function of CDKsand preventsover proliferation of cancer cells thus used to treat cancers. Quinoxaline and its derivatives are an important class of benzoheterocycles displaying a broad spectrum of biological activities which have made them privileged structures in pharmacologically active compounds. Modification in their structure has offered a high degree of diversity that has proven useful for the development of new therapeutic agents having improved potency and lesser toxicity. In the present work, attempts were made to identify leading quinoxaline moieties as candidate drugs against CDK2 by carrying out docking experiments with our in-house synthetic 46 analogues and assigning docking scores. Ten moieties with docking score -5 or above were zoomed in as candidate moieties. Structural features of the above quinoxaline analogues will be presented with a view to arrive at potential drug target for CDK2.